This microRNA downregulates HSP60, a regulator of insulin-like growth factor-1 receptor (IGF-1R) signaling, which is inversely associated with the progression of diabetic cardiomyopathy [121]. This evidence concerns the gene IGF1R and diabetic cardiomyopathy.